Experimental drug trial offers new hope for blood cancer patients

NCT ID NCT05828511

Recruiting now Disease control Sponsor: Regeneron Pharmaceuticals Source: ClinicalTrials.gov ↗

Summary

This study is testing an experimental drug called linvoseltamab for people newly diagnosed with multiple myeloma, a type of blood cancer. The trial aims to find the right dose, check for side effects, and see how well the drug shrinks tumors in 149 participants. It includes both patients who are eligible for stem cell transplant and those who are not.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

CHU De Lille
NOT_YET_RECRUITING

Lille, 59000, France
Centre Hospitalier Universitaire (CHU) Montpellier
RECRUITING

Montpellier, 342950, France
Centre Hospitalier Universitaire (CHU) de Poitiers
RECRUITING

Poitiers, Nouvelle-Aquitaine, 86021, France
Clinica Universidad de Navarra
RECRUITING

Pamplona, Navarre, 31008, Spain
Clinica Universidad de Navarra - Madrid
RECRUITING

Madrid, 28027, Spain
Colorado Blood Cancer Institute/SCRI
RECRUITING

Denver, Colorado, 80218, United States
Columbia University _ New York Presbyterian
RECRUITING

New York, New York, 10032, United States
Duke University Health System (DUHS)
RECRUITING

Durham, North Carolina, 27705, United States
Gustave Roussy
RECRUITING

Villejuif, Île-de-France Region, 94800, France
Hopital Necker
RECRUITING

Paris, Île-de-France Region, 75015, France
Hopital Pitié Salpetriere APHP
RECRUITING

Paris, 75013, France
Hopital Prive d'Antony
RECRUITING

Antony, Île-de-France Region, 92160, France
Hopital Saint Louis
RECRUITING

Paris, 75010, France
Hospital Clinic de Barcelona
RECRUITING

Barcelona, 08036, Spain
Hospital General Universitario Doctor Balmis Alicante
RECRUITING

Alicante, Valencia, 03010, Spain
Hospital Germans Trias i Pujol
RECRUITING

Badalona, Barcelona, 08916, Spain
Hospital Universitario Central de Asturias
RECRUITING

Oviedo, Principality of Asturias, 33011, Spain
Hospital Universitario Quiron Salud Madrid
RECRUITING

Pozuelo de Alarcón, Madrid, 28223, Spain
Hospital Universitario de Salamanca
RECRUITING

Salamanca, 37007, Spain
Institut Catala dOncologia (ICO Hospitalet)
RECRUITING

Barcelona, 08908, Spain
Karmanos Cancer Institute
RECRUITING

Detroit, Michigan, 48201, United States
La Fe University Hospital
RECRUITING

Valencia, 46026, Spain
Levine Cancer Institute
RECRUITING

Charlotte, North Carolina, 28204, United States
Norton Cancer Institute
RECRUITING

Louisville, Kentucky, 40207, United States
Perlmutter Cancer Center
RECRUITING

New York, New York, 10016, United States
Perlmutter Cancer Center at NYU Langone Hospital - Long Island
RECRUITING

Mineola, New York, 11501, United States
Rutgers Cancer Institute of New Jersey
RECRUITING

New Brunswick, New Jersey, 08901, United States
Stony Brook University Hospital
RECRUITING

Stony Brook, New York, 11794, United States
The University of Texas MD Anderson Cancer Center
RECRUITING

Houston, Texas, 77030, United States
UC Irvine Health
RECRUITING

Orange, California, 92868, United States
Universitary Hospital La Princesa
RECRUITING

Madrid, 28006, Spain
University of California Los Angeles (UCLA)
RECRUITING

Los Angeles, California, 90095, United States

Conditions

Explore the condition pages connected to this study.

MULTIPLE MYELOMA